2026-2030年全球攜帶式心臟監測設備市場

全球攜帶式心臟監測設備市場預計將從 2025 年到 2030 年成長至 26.862 億美元，預測期內複合年成長率為 6.7%。

本報告對全球攜帶式心臟監測設備市場進行了全面分析，包括市場規模和預測、趨勢、成長促進因素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。市場成長的原因包括：遠端患者監護合作的拓展加速了門診心臟護理的普及；透過人工智慧整合提高了攜帶式12導聯心電圖的診斷準確性；以及透過與電子健康記錄（EHR）直接整合簡化了提供攜帶式心臟監護資料的工作流程。

本次調查客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模數據、細分市場數據及區域分析，以及供應商格局數據。此外，報告還包含歷史市場規模數據和預測市場規模數據。

本研究指出，以14天連續貼片式心電圖監測取代短期監測設備，將是未來幾年全球攜帶式心臟監測設備市場成長的關鍵促進因素之一。此外，能夠整合分散的門診遠端遙測網路並透過3D向量心電訊號處理實現居家12導聯心電圖合成的獨立於設備的軟體聚合技術，預計也將帶來顯著的市場需求。

目錄

第1章執行摘要

第2章 Technavio 分析

• 分析價格敏感度、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球心臟監測設備市場
• 2020-2024 年設備特定細分市場分析
• 2020-2024 年最終用戶細分市場分析
• 基於模式的細分市場分析，2020-2024 年
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球攜帶式心臟監測設備市場
• 地緣政治衝突的影響：攜帶式心臟監測設備的全球市場。

第7章：五力分析

第8章 市場區隔：依設備

• 比較：按設備
• 攜帶式心電圖儀
• 攜帶式心臟心臟事件記錄器
• 攜帶式心電遙測裝置
• 植物型循環記錄器
• 市場機會：依設備分類

第9章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 門診部
• 醫院
• 診所和心臟中心
• 市場機會：依最終用戶分類

第10章 市場區隔：依治療方式

• 比較：依模態
• 無線裝置
• 有線設備
• 市場機會：依治療方式分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 新加坡
  • 台灣
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • 南非
  • 阿根廷
  • 土耳其
  • UAE
  • 以色列
  • 智利
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Abbott Laboratories
• Baxter International Inc.
• Bionet Co. Ltd.
• Boston Scientific Corp.
• BPL MEDICAL TECHNOLOGIES
• Cardioline SpA
• GE HealthCare Technologies
• Koninklijke Philips NV
• Labtech Ltd.
• Lepu Medical Co. Ltd.
• Medicalgorithmics SA
• Nihon Kohden Corp.
• SCHILLER AG
• VivaLNK Inc.
• ZOLL Medical Corp.

第16章附錄

The global ambulatory cardiac monitoring devices market is forecasted to grow by USD 2686.2 mn during 2025-2030, accelerating at a CAGR of 6.7% during the forecast period. The report on the global ambulatory cardiac monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expanding remote patient monitoring partnerships accelerates outpatient cardiac care adoption, ai integration enhances handheld twelve lead electrocardiogram diagnostic precision, direct electronic health record workflows streamline ambulatory cardiac data delivery.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global ambulatory cardiac monitoring devices market is segmented as below:

By Device

• Ambulatory ECG devices
• Ambulatory cardiac event monitors
• Ambulatory cardiac telemetry devices
• Implantable loop recorders

By End-User

• Ambulatory care centers
• Hospitals
• Clinics and cardiac centers

By Modality

• Wireless devices
• Wired devices

Geography

• North America
  • US
  • Canada
  • Mexico
• Asia
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the fourteen day continuous patch ecg monitoring replaces short duration devices as one of the prime reasons driving the global ambulatory cardiac monitoring devices market growth during the next few years. Also, device neutral software aggregation unifies fragmented outpatient remote telemetry networks and three dimensional vector cardiographic signal processing enables home twelve lead synthesis will lead to sizable demand in the market.

The report on the global ambulatory cardiac monitoring devices market covers the following areas:

• Global ambulatory cardiac monitoring devices market sizing
• Global ambulatory cardiac monitoring devices market forecast
• Global ambulatory cardiac monitoring devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global ambulatory cardiac monitoring devices market vendors that include Abbott Laboratories, ACS Diagnostics Inc., Baxter International Inc., Bionet Co. Ltd., Boston Scientific Corp., BPL MEDICAL TECHNOLOGIES, Cardiac Insight Inc., Cardioline SpA, Cortrium Aps, GE HealthCare Technologies, iRhythm Technologies Inc., Koninklijke Philips NV, Labtech Ltd., Lepu Medical Co. Ltd., Medicalgorithmics S.A., Nihon Kohden Corp., Norav Medical, SCHILLER AG, VivaLNK Inc., ZOLL Medical Corp.. Also, the global ambulatory cardiac monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Device
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Modality
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Ambulatory Cardiac Monitoring Devices Market 2020 - 2024
  • Historic Market Size - Data Table on Global Ambulatory Cardiac Monitoring Devices Market 2020 - 2024 ($ million)
• 5.2 Device segment analysis 2020 - 2024
  • Historic Market Size - Device Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Modality segment analysis 2020 - 2024
  • Historic Market Size - Modality Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global ambulatory cardiac monitoring devices market
• 6.2 Impact of geopolitical conflicts on global ambulatory cardiac monitoring devices market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Device

• 8.1 Market segments
• 8.2 Comparison by Device
• 8.3 Ambulatory ECG devices - Market size and forecast 2025-2030
• 8.4 Ambulatory cardiac event monitors - Market size and forecast 2025-2030
• 8.5 Ambulatory cardiac telemetry devices - Market size and forecast 2025-2030
• 8.6 Implantable loop recorders - Market size and forecast 2025-2030
• 8.7 Market opportunity by Device
  • Market opportunity by Device ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Ambulatory care centers - Market size and forecast 2025-2030
• 9.4 Hospitals - Market size and forecast 2025-2030
• 9.5 Clinics and cardiac centers - Market size and forecast 2025-2030
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Modality

• 10.1 Market segments
• 10.2 Comparison by Modality
• 10.3 Wireless devices - Market size and forecast 2025-2030
• 10.4 Wired devices - Market size and forecast 2025-2030
• 10.5 Market opportunity by Modality
  • Market opportunity by Modality ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Asia - Market size and forecast 2025-2030
  • 12.4.1 China - Market size and forecast 2025-2030
  • 12.4.2 Japan - Market size and forecast 2025-2030
  • 12.4.3 India - Market size and forecast 2025-2030
  • 12.4.4 South Korea - Market size and forecast 2025-2030
  • 12.4.5 Singapore - Market size and forecast 2025-2030
  • 12.4.6 Taiwan - Market size and forecast 2025-2030
• 12.5 Europe - Market size and forecast 2025-2030
  • 12.5.1 Germany - Market size and forecast 2025-2030
  • 12.5.2 UK - Market size and forecast 2025-2030
  • 12.5.3 France - Market size and forecast 2025-2030
  • 12.5.4 Italy - Market size and forecast 2025-2030
  • 12.5.5 Spain - Market size and forecast 2025-2030
  • 12.5.6 The Netherlands - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 South Africa - Market size and forecast 2025-2030
  • 12.6.4 Argentina - Market size and forecast 2025-2030
  • 12.6.5 Turkey - Market size and forecast 2025-2030
  • 12.6.6 UAE - Market size and forecast 2025-2030
  • 12.6.7 Israel - Market size and forecast 2025-2030
  • 12.6.8 Chile - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Expanding remote patient monitoring partnerships accelerates outpatient cardiac care adoption
  • AI integration enhances handheld twelve lead electrocardiogram diagnostic precision
  • Direct electronic health record workflows streamline ambulatory cardiac data delivery
• 13.2 Market challenges
  • Strict reimbursement governance restricts financial feasibility across outpatient cardiac diagnostics
  • Company fragmentation prevents seamless electronic health record system data interoperability
  • Cybersecurity vulnerabilities jeopardize data privacy in connected remote cardiac sensors
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Fourteen day continuous patch ECG monitoring replaces short duration devices
  • Device neutral software aggregation unifies fragmented outpatient remote telemetry networks
  • Three dimensional vector cardiographic signal processing enables home twelve lead synthesis

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Baxter International Inc.
  • Baxter International Inc. - Overview
  • Baxter International Inc. - Business segments
  • Baxter International Inc. - Key news
  • Baxter International Inc. - Key offerings
  • Baxter International Inc. - Segment focus
  • SWOT
• 15.6 Bionet Co. Ltd.
  • Bionet Co. Ltd. - Overview
  • Bionet Co. Ltd. - Product / Service
  • Bionet Co. Ltd. - Key offerings
  • SWOT
• 15.7 Boston Scientific Corp.
  • Boston Scientific Corp. - Overview
  • Boston Scientific Corp. - Business segments
  • Boston Scientific Corp. - Key offerings
  • Boston Scientific Corp. - Segment focus
  • SWOT
• 15.8 BPL MEDICAL TECHNOLOGIES
  • BPL MEDICAL TECHNOLOGIES - Overview
  • BPL MEDICAL TECHNOLOGIES - Product / Service
  • BPL MEDICAL TECHNOLOGIES - Key offerings
  • SWOT
• 15.9 Cardioline SpA
  • Cardioline SpA - Overview
  • Cardioline SpA - Product / Service
  • Cardioline SpA - Key offerings
  • SWOT
• 15.10 GE HealthCare Technologies
  • GE HealthCare Technologies - Overview
  • GE HealthCare Technologies - Business segments
  • GE HealthCare Technologies - Key news
  • GE HealthCare Technologies - Key offerings
  • GE HealthCare Technologies - Segment focus
  • SWOT
• 15.11 Koninklijke Philips NV
  • Koninklijke Philips NV - Overview
  • Koninklijke Philips NV - Business segments
  • Koninklijke Philips NV - Key news
  • Koninklijke Philips NV - Key offerings
  • Koninklijke Philips NV - Segment focus
  • SWOT
• 15.12 Labtech Ltd.
  • Labtech Ltd. - Overview
  • Labtech Ltd. - Product / Service
  • Labtech Ltd. - Key offerings
  • SWOT
• 15.13 Lepu Medical Co. Ltd.
  • Lepu Medical Co. Ltd. - Overview
  • Lepu Medical Co. Ltd. - Product / Service
  • Lepu Medical Co. Ltd. - Key offerings
  • SWOT
• 15.14 Medicalgorithmics S.A.
  • Medicalgorithmics S.A. - Overview
  • Medicalgorithmics S.A. - Product / Service
  • Medicalgorithmics S.A. - Key offerings
  • SWOT
• 15.15 Nihon Kohden Corp.
  • Nihon Kohden Corp. - Overview
  • Nihon Kohden Corp. - Business segments
  • Nihon Kohden Corp. - Key offerings
  • Nihon Kohden Corp. - Segment focus
  • SWOT
• 15.16 SCHILLER AG
  • SCHILLER AG - Overview
  • SCHILLER AG - Product / Service
  • SCHILLER AG - Key offerings
  • SWOT
• 15.17 VivaLNK Inc.
  • VivaLNK Inc. - Overview
  • VivaLNK Inc. - Product / Service
  • VivaLNK Inc. - Key offerings
  • SWOT
• 15.18 ZOLL Medical Corp.
  • ZOLL Medical Corp. - Overview
  • ZOLL Medical Corp. - Product / Service
  • ZOLL Medical Corp. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations